0.00Open0.06Pre Close0 Volume127 Open Interest73.00Strike Price0.00Turnover2029.41%IV8.56%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.0347Delta0.0179Gamma1329.50Leverage Ratio-61.4660Theta0.0000Rho-46.19Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet